BioWorld

Feb. 19, 2009

View Archived Issues

GPC Biotech, Agennix Team to Form New Cancer Firm

Cancer drugmakers GPC Biotech AG and Agennix Inc. have signed an agreement to merge their businesses to form a new company. (BioWorld Today) Read More

Algeta Brings in $35M Privately for Alpharadin Work in HRPC

Read More

Targeting Osteoclast Precursor Could Alleviate Osteoporosis

Read More

NewCo News: KAHR's Third-Generation Biologics Attract Financing

Read More

Neuropharm Plummets 82% as Phase III Autism Trial Fails

Read More

Other News To Note

Read More

Clinic Roundup

Read More